Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-14 Sale |
2025-02-18 4:05 pm |
Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer |
5,561 | $3.96 | $22,022 | 68,852 (Direct) |
View |
| 2024-12-03 Sale |
2024-12-04 5:04 pm |
Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer |
5,072 | $5.5986 | $28,396 | 41,766 (Direct) |
View |
| 2023-12-04 Sale |
2023-12-05 2:32 pm |
Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer |
5,367 | $2.78 | $14,920 | 46,838 (Direct) |
View |
| 2020-06-22 Sale |
2020-06-22 9:17 pm |
Sarepta Therapeutics Inc. | SRPT | Howton David T EVP, General Counsel |
105,122 | $170.88 | $17,962,831 | 39,579 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Exercise |
2025-02-18 4:05 pm |
N/A N/A |
Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer |
14,687 | $0 | 68,852 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-11 4:38 pm |
N/A N/A |
Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer |
169,100 | $0 | 169,100 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 5:04 pm |
N/A N/A |
Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer |
13,051 | $0 | 41,766 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 11:28 am |
N/A 2034-02-13 |
Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer |
176,250 | $0 | 176,250 (Direct) |
View |
| 2023-12-02 Exercise |
2023-12-05 2:32 pm |
N/A N/A |
Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer |
13,051 | $0 | 46,838 (Direct) |
View |
| 2022-12-02 Option Award |
2022-12-05 5:50 pm |
N/A 2032-12-02 |
Solid Biosciences Inc. | SLDB | Howton David T See Remarks |
156,615 | $0 | 156,615 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-22 9:17 pm |
2017-02-28 2026-02-28 |
Sarepta Therapeutics Inc. | SRPT | Howton David T EVP, General Counsel |
105,122 | $0 | 39,579 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-22 9:17 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Howton David T EVP, General Counsel |
3,138 | $13.71 | 39,579 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-22 9:17 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Howton David T EVP, General Counsel |
56,984 | $23.85 | 39,579 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-22 9:17 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Howton David T EVP, General Counsel |
45,000 | $29.03 | 39,579 (Direct) |
View |